Photo Credit: IANS

IANSLive

New Delhi, April 12 (IANS) The Russian Direct Investment Fund said on Monday it is "awaiting imminently" the recommendation by the Subject Expert Committee (SEC) of India's Central Drugs Standard Control Organisation (CDSCO) to approve the use of the Russian Sputnik V vaccine against coronavirus in the country.

To get full access of the story, click here to subscribe to IANS News Service

© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.

For news, views and gossips, follow IANS at Twitter.

Update: 12-April-2021